Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein (Q34543291)

2 August 2017

Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein (English)

1 reference

2 August 2017

multiple drug resistance

1 reference

Jun-Sheng Wang

1

1 reference

2 August 2017

Hao-Jie Zhu

2

1 reference

2 August 2017

John S Markowitz

3

1 reference

2 August 2017

Jennifer L Donovan

4

1 reference

2 August 2017

C Lindsay DeVane

5

1 reference

2 August 2017

30 June 2006

1 reference

2 August 2017

1 reference

2 August 2017

187

1 reference

2 August 2017

4

1 reference

2 August 2017

415-423

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-006-0437-9

2 August 2017

0 references

cites work

Evaluation of treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

Clozapine eligibility among state hospital patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

Postmortem distribution of the novel antipsychotic drug quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

Effects of stringent criteria on eligibility for clozapine among public mental health clients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

Treatment of the neuroleptic-nonresponsive schizophrenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0437-9

The current status of PET scanning with respect to schizophrenia

21 January 2018

1 reference

12 December 2020

Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats

1 reference

12 December 2020

Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.

1 reference

12 December 2020

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates

1 reference

12 December 2020

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

12 December 2020

Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds

1 reference

12 December 2020

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

12 December 2020

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

1 reference

12 December 2020

Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes

1 reference

12 December 2020

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

1 reference

12 December 2020

Itraconazole decreases renal clearance of digoxin

1 reference

12 December 2020

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

1 reference

12 December 2020

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

1 reference

12 December 2020

Quinidine reduces biliary clearance of digoxin in man.

1 reference

12 December 2020

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

1 reference

12 December 2020

Role of transport proteins in drug absorption, distribution and excretion

1 reference

12 December 2020

Disposition and metabolism of [14C]-haloperidol in rats.

1 reference

12 December 2020

MDR1 gene expression in brain of patients with medically intractable epilepsy

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells

1 reference

12 December 2020

Extrapyramidal symptoms in patients treated with risperidone

1 reference

12 December 2020

Effect of clarithromycin on steady-state digoxin concentrations

1 reference

12 December 2020

An evaluation of risperidone drug interactions

1 reference

12 December 2020

Heterologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs

1 reference

12 December 2020

Over-expression of P-glycoprotein in malformations of cortical development.

1 reference

12 December 2020

Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study

1 reference

12 December 2020

Effect of quinidine on digoxin bioavailability

1 reference

12 December 2020

Dopamine D(2) receptor blockade in schizophrenia

1 reference

12 December 2020

P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil

1 reference

12 December 2020

Increased drug delivery to the brain by P-glycoprotein inhibition

1 reference

12 December 2020

Itraconazole increases serum digoxin concentration

1 reference

12 December 2020

Interactions between the cytochrome P450 system and the second-generation antipsychotics

1 reference

12 December 2020

Clinical aspects and biological bases of drug-resistant epilepsies

1 reference

12 December 2020

Multidrug-resistance protein 1 in focal cortical dysplasia.

1 reference

12 December 2020

Pharmacokinetics of chlorpromazine and key metabolites

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol

1 reference

12 December 2020

Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service

1 reference

12 December 2020

Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of olanzapine in rats

1 reference

12 December 2020

Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats

1 reference

12 December 2020

A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier

1 reference

12 December 2020

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.

1 reference

12 December 2020

Influence of verapamil on the inotropism and pharmacokinetics of digoxin

1 reference

12 December 2020

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers

1 reference

12 December 2020

Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies

1 reference

12 December 2020

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

1 reference

12 December 2020

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

1 reference

12 December 2020

Therapeutic monitoring of new antipsychotic drugs

1 reference

12 December 2020

Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively

1 reference

12 December 2020

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

1 reference

12 December 2020

10.1007/S00213-006-0437-9

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference